Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for INNOVATE (VATE) over the last 16 years, with Sep 2025 value amounting to $913.2 million.

  • INNOVATE's Liabilities and Shareholders Equity rose 1.78% to $913.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year decrease of 5.82%. This contributed to the annual value of $891.1 million for FY2024, which is 14.61% down from last year.
  • Latest data reveals that INNOVATE reported Liabilities and Shareholders Equity of $913.2 million as of Q3 2025, which was up 2.50% from $890.9 million recorded in Q2 2025.
  • Over the past 5 years, INNOVATE's Liabilities and Shareholders Equity peaked at $6.9 billion during Q2 2021, and registered a low of $868.0 million during Q1 2025.
  • Over the past 3 years, INNOVATE's median Liabilities and Shareholders Equity value was $913.2 million (recorded in 2025), while the average stood at $960.6 million.
  • Within the past 5 years, the most significant YoY rise in INNOVATE's Liabilities and Shareholders Equity was 6.58% (2022), while the steepest drop was 84.05% (2022).
  • Over the past 5 years, INNOVATE's Liabilities and Shareholders Equity (Quarterly) stood at $1.1 billion in 2021, then increased by 6.58% to $1.2 billion in 2022, then declined by 9.39% to $1.0 billion in 2023, then declined by 14.61% to $891.1 million in 2024, then grew by 1.78% to $913.2 million in 2025.
  • Its Liabilities and Shareholders Equity was $913.2 million in Q3 2025, compared to $890.9 million in Q2 2025 and $868.0 million in Q1 2025.